IBillionaire

IBillionaire is a New York-based company specializing in the development and marketing of CBD gummies designed to enhance sleep quality and promote relaxation among consumers seeking natural wellness solutions. Founded in 2013 and headquartered in New York, IBillionaire focuses on producing CBD and THC-infused gummies targeting various consumer wellness needs. The company has successfully completed a total of 6 deals, with its most recent funding round being a Series A round in which it raised USD 1. 00 mn from NXTP Ventures.

The founder's previous entrepreneurial experience is not publicly available. IBillionaire primarily develops and markets a range of CBD gummies aimed at improving sleep quality and relaxation. Their product line includes various flavors of THC and CBD-infused gummies that cater to needs such as pain relief, anxiety reduction, and sleep support. Formulated with natural ingredients, these products comply with U.

S. regulations and are available in multiple states and selected international markets, appealing to health-conscious consumers and those with sleep disorders. IBillionaire generates revenue through direct-to-consumer sales and subscription models, allowing customers to receive products regularly. The company offers one-time purchase options and recurring subscriptions, enhancing customer convenience.

Pricing is competitive, with savings available for subscription services, fostering customer loyalty and streamlining operations. IBillionaire plans to expand its product line with new CBD gummies designed for enhanced sleep support expected to launch in late 2024. The company is also targeting expansion into new markets, particularly in Europe and Canada, by mid-2025. The recent funding from the Series A round will be utilized to support these product development initiatives and market expansion efforts.